Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07506577 · ClinicalTrials.gov registry record · NA
Impact of Saccharin and Acesulfame-Potassium on Glycemia
A NA study, sponsored by Virginia Polytechnic Institute and State University.
- Completed
- Registry status
- NA
- Development phase
- 14
- Enrollment target
NCT07506577 is a NA study that has completed, run by Virginia Polytechnic Institute and State University. The registered enrollment target is 14 participants.
The verdict
NCT07506577, a NA study, has completed, sponsored by Virginia Polytechnic Institute and State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 14 participants
- Enrollment target
Study Summary
The major purpose of this research project is to learn if consuming artificial sweeteners have any impact on glucose levels in adults at high risk for developing type 2 diabetes. People may be at risk for diabetes if you are a middle-aged or older adult. Briefly, the full study is 3 weeks long with 3 controlled feeding visits. Which means participants will eat all of the food and drinks that we provide to them for breakfast. Participants will come to the lab in the morning to eat breakfast, and we will monitor changes in blood glucose over a 2 hour period. Participants will be randomized into 1 of 3 groups: 1 group will receive acesulfame-potassium, 1 group will receive saccharin, and 1 group will receive no artificial sweeteners. Participants will experience a different group each visit, with about 7 days between each visit. We will be examining if consuming artificial sweeteners has any impact on glucose levels.
Interventions
- OTHER non-sugar sweetener - saccharin
- OTHER non-sugar sweetener - acesulfame potassium
- OTHER non-sugar sweetener - control
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 14 participants |
| Start Date | 2022-07-30 |
| Est. Completion | 2025-05-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07506577
The ClinicalTrials.gov registry entry for NCT07506577 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 14 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Virginia Polytechnic Institute and State University, which has 104 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which non-sugar sweetener - saccharin is the first listed.
NCT07506577 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07506577 about?
NCT07506577 is a clinical study titled "Impact of Saccharin and Acesulfame-Potassium on Glycemia". The major purpose of this research project is to learn if consuming artificial sweeteners have any impact on glucose levels in adults at high risk for developing type 2 diabetes. People may be at risk for diabetes if you are a middle-aged or older adult. Briefly, the full study is 3 weeks long with ...
What is the current status of trial NCT07506577?
This trial is currently completed. It is a NA study. The enrollment target is 14 participants. The study started on 2022-07-30. Estimated completion is 2025-05-01.
What interventions are being tested in trial NCT07506577?
The interventions under investigation include: non-sugar sweetener - saccharin (OTHER), non-sugar sweetener - acesulfame potassium (OTHER), non-sugar sweetener - control (OTHER).
Who is sponsoring clinical trial NCT07506577?
This trial is sponsored by Virginia Polytechnic Institute and State University, which has 104 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.